Cost-Effectiveness of Tissue-Type Plasminogen Activator in the 3- to 4.5-Hour Time Window for Acute Ischemic Stroke
Author(s) -
Christie E. Tung,
Sandra Win,
Maarten G. Lansberg
Publication year - 2011
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.111.615682
Subject(s) - medicine , quality adjusted life year , tissue plasminogen activator , cost effectiveness , stroke (engine) , thrombolysis , cost effectiveness analysis , emergency medicine , surgery , mechanical engineering , risk analysis (engineering) , myocardial infarction , engineering
The aim of this study was to determine the cost-effectiveness of tissue-type plasminogen activator (tPA) treatment in the 3- to 4.5-hour time window after ischemic stroke.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom